Dopamine D3 and 5-HT1B receptor dysregulation as a result of psychostimulant intake and forced abstinence: Implications for medications development

Neuropharmacology

Volumn 76, Issue PART B, 2014, Pages 301-319

  Neisewander, Janet L ^a   Cheung, Timothy H C ^a   Pentkowski, Nathan S ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Addiction; Amphetamine; Cocaine; Incentive motivation; Reinstatement extinction; Self administration

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; AMPHETAMINE; ARIPIPRAZOLE; COCAINE; DOPAMINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; ETICLOPRIDE; L 745829; N (2,6 DIMETHYLERGOLIN 8ALPHA YL)PIVALAMIDE; N [4 [2 (6 CYANO 1,2,3,4 TETRAHYDRO 2 ISOQUINOLINYL)ETHYL]CYCLOHEXYL] 4 QUINOLINECARBOXAMIDE; N [4 [2 (8 CYANO 1,3A,4,9B TETRAHYDRO 1 BENZOPYRANO[3,4 C]PYRROL 2(3H) YL)ETHYL]PHENYL]ACETAMIDE; NGB 2904; PF 592379; PG 01037; PRAMIPEXOLE; PSYCHOSTIMULANT AGENT; QUINELORANE; QUINPIROLE; RACLOPRIDE; SEROTONIN; SEROTONIN 1B AGONIST; SEROTONIN 1B RECEPTOR; SULPIRIDE; TERGURIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; WC 10; WC 44;

ABSTINENCE; ADAPTATION; COCAINE DEPENDENCE; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; DRUG SELF ADMINISTRATION; DRUG TARGETING; HUMAN; METHAMPHETAMINE DEPENDENCE; NONHUMAN; PRIORITY JOURNAL; RELAPSE; REVIEW; SEROTONINERGIC SYSTEM; SOCIAL ASPECT; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

5-HT(1B) RECEPTORS; 5-HT(1B)RS; A(2A)RS; ADDICTION; ADENOSINE A(2A) RECEPTORS; AMPHETAMINE; BASOLATERAL AMYGDALA; BLA; CEA; CENTRAL AMYGDALA; COCAINE; D3RS; DOPAMINE D3 RECEPTORS; DORSAL STRIATUM; DST; ELEVATED PLUS MAZE; EPM; FIXED RATIO; FR; INCENTIVE MOTIVATION; NAC; NACC; NACSH; NUCLEUS ACCUMBENS; NUCLEUS ACCUMBENS CORE; NUCLEUS ACCUMBENS SHELL; OBSESSIVE-COMPULSIVE DISORDER; OCD; PR; PROGRESSIVE RATIO; REINSTATEMENT/EXTINCTION; SA; SELF-ADMINISTRATION; VARIABLE INTERVAL; VENTRAL TEGMENTAL AREA; VI; VTA;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; HUMANS; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, DOPAMINE D3; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84887120554     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.08.014     Document Type: Review

References (243)

1. C. Achat-Mendes, P. Grundt, J. Cao, D.M. Platt, A.H. Newman, and R.D. Spealman Dopamine D3 and D2 receptor mechanisms in the abuse-related behavioral effects of cocaine: studies with preferential antagonists in squirrel monkeys J. Pharmacol. Exp. Ther. 334 2010 556 565
2. C. Achat-Mendes, D.M. Platt, A.H. Newman, and R.D. Spealman The dopamine D3 receptor partial agonist CJB 090 inhibits the discriminative stimulus but not the reinforcing or priming effects of cocaine in squirrel monkeys Psychopharmacology 206 2009 73 84
3. J.I. Acosta, F.A. Boynton, K.F. Kirschner, and J.L. Neisewander Stimulation of 5-HT1B receptors decreases cocaine- and sucrose-seeking behavior Pharmacol. Biochem. Behav. 80 2005 297 307 (Pubitemid 40170427)
4. J.E. Ahlskog Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease Physiol. Behav. 104 2011 168 172
5. S.H. Ahmed, P.J. Kenny, G.F. Koob, and A. Markou Neurobiological evidence for hedonic allostasis associated with escalating cocaine use Nat. Neurosci. 5 2002 625 626 (Pubitemid 34742974)
6. S.H. Ahmed, and G.F. Koob Transition from moderate to excessive drug intake: change in hedonic set point Science 282 1998 298 300 (Pubitemid 28487203)
7. K. Akimoto, T. Hamamura, Y. Kazahaya, K. Akiyama, and S. Otsuki Enhanced extracellular dopamine level may Be the fundamental neuropharmacological basis of cross-behavioral sensitization between methamphetamine and cocaine - an in vivo dialysis study in freely moving rats Brain Res. 507 1990 344 346 (Pubitemid 20054122)
8. S.M. Anderson, H.D. Schmidt, and R.C. Pierce Administration of the D2 dopamine receptor antagonist sulpiride into the shell, but not the core, of the nucleus accumbens attenuates cocaine priming-induced reinstatement of drug seeking Neuropsychopharmacology 31 2006 1452 1461
9. S.M. Antelman, and A.R. Caggiula Oscillation follows drug sensitization: implications Crit. Rev. Neurobiol. 10 1996 101 117 (Pubitemid 26283957)
10. A.R. Ase, T.A. Reader, R. Hen, M. Riad, and L. Descarries Altered serotonin and dopamine metabolism in the CNS of serotonin 5-HT(1A) or 5-HT(1B) receptor knockout mice J. Neurochem. 75 2000 2415 2426
11. V. Audinot, A. Newman-Tancredi, A. Gobert, J.M. Rivet, M. Brocco, F. Lejeune, L. Gluck, I. Desposte, K. Bervoets, A. Dekeyne, and M.J. Millan A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194 JJ Pharmacol. Exp. Ther. 287 1998 187 197 (Pubitemid 29140201)
12. M.T. Bardo, J.L. Neisewander, and T.H. Kelly Psychosocial influences on the neurobehavioral pharmacology of abused drugs Pharmacol. Rev. 65 2013 255 290
13. A.M. Barr, and A.G. Phillips Withdrawal following repeated exposure to d-amphetamine decreases responding for a sucrose solution as measured by a progressive ratio schedule of reinforcement Psychopharmacology 141 1999 99 106 (Pubitemid 29193301)
14. A.C. Barrett, J.R. Miller, J.M. Dohrmann, and S.B. Caine Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats Neuropharmacology 47 2004 256 273 (Pubitemid 39298269)
15. C. Bendotti, and R. Samanin The role of putative 5-HT1A and 5-HT1B receptors in the control of feeding in rats Life Sci. 41 1987 635 642 (Pubitemid 17097818)
16. ®) Exp. Clin. Psychopharmacol. 16 2008 475 483
17. B.L. Blaylock, R.W. Gould, A. Banala, P. Grundt, R.R. Luedtke, A.H. Newman, and M.A. Nader Influence of cocaine history on the behavioral effects of dopamine D-3 receptor-selective compounds in monkeys Neuropsychopharmacology 36 2011 1104 1113
18. I. Boileau, D. Payer, S. Houle, A. Behzadi, P.M. Rusjan, J.C. Tong, D. Wilkins, P. Selby, T.P. George, M. Zack, Y. Furukawa, T. McCluskey, A.A. Wilson, and S.J. Kish Higher binding of the dopamine D3 receptor-preferring ligand [C-11] -(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study J. Neurosci. 32 2012 1353 1359
19. U. Boschert, D.A. Amara, L. Segu, and R. Hen The mouse 5-hydroxytryptamine1B receptor is localized predominantly on axon terminals Neuroscience 58 1994 167 182
20. M.L. Boshuisen, and J.A. den Boer Zolmitriptan (a 5-HT1B/1D receptor agonist with central action) does not increase symptoms in obsessive compulsive disorder Psychopharmacology (Berl) 152 2000 74 79
21. A.T. Bruinvels, B. Landwehrmeyer, E.L. Gustafson, M.M. Durkin, G. Mengod, T.A. Branchek, D. Hoyer, and J.M. Palacios Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain Neuropharmacology 33 1994 367 386
22. E.S. Burstein, J. Ma, S. Wong, Y. Gao, E. Pham, A.E. Knapp, N.R. Nash, R. Olsson, R.E. Davis, U. Hacksell, D.M. Weiner, and M.R. Brann Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist J Pharmacol. Exp. Ther. 315 2005 1278 1287 (Pubitemid 41635416)
23. S.B. Caine, and G.F. Koob Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat Behav. Pharmacol. 6 1995 333 347
24. S.B. Caine, G.F. Koob, L.H. Parsons, B.J. Everitt, J.C. Schwartz, and P. Sokoloff D3 receptor test in vitro predicts decreased cocaine self-administration in rats Neuroreport 8 1997 2373 2377 (Pubitemid 27319704)
25. S.B. Caine, S.S. Negus, N.K. Mello, and J. Bergman Effects of dopamine D(1-like) and D(2-like) agonists in rats that self- administer cocaine J Pharmacol. Exp. Ther. 291 1999 353 360 (Pubitemid 29451610)
26. S.B. Caine, S.S. Negus, N.K. Mello, S. Patel, L. Bristow, J. Kulagowski, D. Vallone, A. Saiardi, and E. Borrelli Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists J. Neurosci. 22 2002 2977 2988 (Pubitemid 37465846)
27. S.B. Caine, M. Thomsen, A.C. Barrett, G.T. Collins, P. Grundt, A.H. Newman, P. Butler, and M. Xu Cocaine self-administration in dopamine D3 receptor knockout mice Exp. Clin. Psychopharmacol. 20 2012 352 363
28. J. Cao, E. Larocque, and D. Li Associations of the 5-hydroxytryptamine (serotonin) receptor 1B gene (HTR1B) with alcohol, cocaine, and heroin abuse Am. J. Med. Genet. B Neuropsychiatr. Genet. 162B 2 2013 169 176
29. J.X. Cao, J. Hu, X.M. Ye, Y. Xia, C.A. Haile, T.R. Kosten, and X.Y. Zhang Association between the 5-HTR1B gene polymorphisms and alcohol dependence in a Han Chinese population Brain Res. 1376 2011 1 9
30. 2 dopamine receptors Neuropsychopharmacology 28 2003 1150 1159
31. L. Cervo, F. Carnovali, J.A. Stark, and T. Mennini Cocaine-seeking behavior in response to drug-associated stimuli in rats: involvement receptors of D-3 and D-2 dopamine receptors Neuropsychopharmacology 28 2003 1150 1159
32. L. Cervo, A. Cocco, C. Petrella, and C.A. Heidbreder Selective antagonism at dopamine D3 receptors attenuates cocaine-seeking behaviour in the rat Int. J. Neuropsychopharmacol. 10 2007 167 181
33. L. Cervo, A. Cocco, C. Petrella, and C.A. Heidbreder Selective antagonism at dopamine D(3) receptors attenuates cocaine-seeking behaviour in the rat Int. J. Neuropsychopharmacol. 10 2007 167 181
34. L. Cervo, M. Rozio, C.B. Ekalle-Soppo, F. Carnovali, E. Santangelo, and R. Samanin Stimulation of serotonin1B receptors induces conditioned place aversion and facilitates cocaine place conditioning in rats Psychopharmacology (Berl) 163 2002 142 150 (Pubitemid 35013605)
35. W.L. Chang, M.R. Breier, A. Yang, and N.R. Swerdlow Disparate effects of pramipexole on locomotor activity and sensorimotor gating in Sprague-Dawley rats Pharmacol. Biochem. Behav. 99 2011 634 638
36. F. Chaouloff, H. Courvoisier, M.P. Moisan, and P. Mormede GR 127935 reduces basal locomotor activity and prevents RU 24969-, but not D-amphetamine-induced hyperlocomotion, in the Wistar-Kyoto hyperactive (WKHA) rat Psychopharmacology (Berl) 141 1999 326 331 (Pubitemid 29196083)
37. S.C. Cheetham, and D.J. Heal Evidence that RU 24969-induced locomotor activity in C57/B1/6 mice is specifically mediated by the 5-HT1B receptor Br. J. Pharmacol. 110 1993 1621 1629
38. T.H.C. Cheung, B.C. Nolan, L.R. Hammerslag, S.M. Weber, J.P. Durbin, N.A. Peartree, R.H. Mach, R.R. Luedtke, and J.L. Neisewander Phenylpiperazine derivatives with selectivity for dopamine D3 receptors modulate cocaine self-administration in rats Neuropharmacology 63 2012 1346 1359
39. T.H.C. Cheung, A.L. Loriaux, S.M. Weber, K.N. Chandler, J.D. Lenz, R.F. Schaan, R.H. Mach, R.R. Luedtke, and J.L. Neisewander Reduction of cocaine self-administration and D3 receptor-mediated behavior by two novel dopamine D3 receptor-selective partial agonists, OS-3-106 and WW-III-55 J. Pharmacol. Exp. Ther. 2013 (in press)
40. A. Childress, R. Ehrman, A.T. McLellan, and C. O'Brien Conditioned craving and arousal in cocaine addiction: a preliminary report NIDA Res. Monogr. 81 1988 74 80
41. A.R. Childress, A.T. McLellan, R. Ehrman, and C.P. O'Brien Classically conditioned responses in opioid and cocaine dependence: a role in relapse? NIDA Res. Monogr. 84 1988 25 43
42. W.H. Chu, Z. Tu, E. McElveen, J.B. Xu, M. Taylor, R.R. Luedtke, and R.H. Mach Synthesis and in vitro binding of N-phenyl piperazine analogs as potential dopamine D-3 receptor ligands Bioorg. Med. Chem. 13 2005 77 87 (Pubitemid 39575694)
43. T. Cigler, K.S. LaForge, P.F. McHugh, S.U. Kapadia, S.M. Leal, and M.J. Kreek Novel and previously reported single-nucleotide polymorphisms in the human 5-HT(1B) receptor gene: no association with cocaine or alcohol abuse or dependence Am. J. Med. Genet. 105 2001 489 497 (Pubitemid 32729814)
44. G.T. Collins, P. Butler, C. Wayman, S. Ratcliffe, P. Gupta, G. Oberhofer, and S.B. Caine Lack of abuse potential in a highly selective dopamine D-3 agonist, PF-592,379, in drug self-administration and drug discrimination in rats Behav. Pharmacol. 23 2012 280 291
45. G.T. Collins, A.R. Cunningham, J.Y. Chen, S.M. Wang, A.H. Newman, and J.H. Woods Effects of pramipexole on the reinforcing effectiveness of stimuli that were previously paired with cocaine reinforcement in rats Psychopharmacology 219 2012 123 135
46. G.T. Collins, A.H. Newman, P. Grundt, K.C. Rice, S.M. Husbands, C. Chauvignac, J.Y. Chen, S.M. Wang, and J.H. Woods Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists Psychopharmacology 193 2007 159 170 (Pubitemid 47025018)
47. G.T. Collins, Y.N.T. Truong, B. Levant, J.Y. Chen, S.M. Wang, and J.H. Woods Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivity Psychopharmacology 215 2011 609 620
48. G.T. Collins, J.M. Witkin, A.H. Newman, K.A. Svensson, P. Grundt, J.J. Cao, and J.H. Woods Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior J Pharmacol. Exp. Ther. 314 2005 310 319 (Pubitemid 41058268)
49. G.T. Collins, and J.H. Woods Influence of conditioned reinforcement on the response-maintaining effects of quinpirole in rats Behav. Pharmacol. 20 2009 492 504
50. K.L. Conrad, K. Ford, M. Marinelli, and M.E. Wolf Dopamine receptor expression and distribution dynamically change in the rat nucleus accumbens after withdrawal from cocaine self-administration Neuroscience 169 2010 182 194
51. P.W. Czoty, and M.A. Nader Effects of dopamine D2/D3 receptor ligands on food-cocaine choice in socially housed male cynomolgus monkeys J Pharmacol. Exp. Ther. 344 2013 329 338
52. A. Dagher, and T.W. Robbins Personality, addiction, dopamine: insights from Parkinson's disease Neuron 61 2009 502 510
53. P. Dayalu, and K.L. Chou Antipsychotic-induced extrapyramidal symptoms and their management Expert Opin. Pharmacother. 9 2008 1451 1462 (Pubitemid 352005909)
54. P. De Fazio, P. Girardi, G. Maina, M.C. Mauri, M. Mauri, P. Monteleone, G.I. Perini, G. Perugi, and A. Rossi Aripiprazole in acute mania and long-term treatment of bipolar disorder: a critical review by an Italian working group Clin. Drug Investig. 30 2010 827 841
55. T.J. De Vries, A.N.M. Schoffelmeer, R. Binnekade, H. Raaso, and L. Vanderschuren Relapse to cocaine- and heroin-seeking behavior mediated by dopamine D2 receptors is time-dependent and associated with behavioral sensitization Neuropsychopharmacology 26 2002 18 26 (Pubitemid 34075273)
56. T.J. De Vries, A.N.M. Schoffelmeer, R. Binnekade, and L. Vanderschuren Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administration Psychopharmacology 143 1999 254 260 (Pubitemid 29204978)
57. F.S. den Boon, S. Body, C.L. Hampson, C.M. Bradshaw, E. Szabadi, and N. de Bruin Effects of amisulpride and aripiprazole on progressive-ratio schedule performance: comparison with clozapine and haloperidol J. Psychopharmacol. 26 2012 1231 1243
58. P. Di Ciano Drug seeking under a second-order schedule of reinforcement depends on dopamine D3 receptors in the basolateral amygdala Behav. Neurosci. 122 2008 129 139 (Pubitemid 351389711)
59. P. Di Ciano, R.J. Underwood, J.J. Hagan, and B.J. Everitt Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A Neuropsychopharmacology 28 2003 329 338
60. C. Dias, S. Lachize, V. Boilet, E. Huitelec, and M. Cador Differential effects of dopaminergic agents on locomotor sensitisation and on the reinstatement of cocaine-seeking and food-seeking behaviour Psychopharmacology 175 2004 414 427 (Pubitemid 39362039)
61. J. Diaz, C. Pilon, B. Le Foll, C. Gros, A. Triller, J.C. Schwartz, and P. Sokoloff Dopamine D3 receptors expressed by all mesencephalic dopamine neurons J. Neurosci. 20 2000 8677 8684
62. E. Doucet, M. Pohl, C.M. Fattaccini, J. Adrien, S.E. Mestikawy, and M. Hamon In situ hybridization evidence for the synthesis of 5-HT1B receptor in serotoninergic neurons of anterior raphe nuclei in the rat brain Synapse 19 1995 18 28
63. A. Drago, S. Alboni, N. Brunello, D. De Ronchi, and A. Serretti HTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memory Eur. J. Clin. Pharmacol. 66 2010 5 27
64. C.E. Evans, and J. Sebastian Serotonin syndrome Emerg. Med. J.: EMJ 24 2007 e20
65. R.W. Evans The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and triptans: an analysis of the 29 case reports MedGenMed 9 2007 48
66. M.W. Feltenstein, C.A. Altar, and R.E. See Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse Biol. Psychiatry 61 2007 582 590 (Pubitemid 46328850)
67. M.W. Feltenstein, P.H. Do, and R.E. See Repeated aripiprazole administration attenuates cocaine seeking in a rat model of relapse Psychopharmacology 207 2009 401 411
68. S. Fenu, J. Wardas, and M. Morelli Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease Behav. Pharmacol. 20 2009 363 379
69. K.B. Freeman, D.J. Heal, A.C. McCreary, and W.L. Woolverton Assessment of ropinirole as a reinforcer in rhesus monkeys Drug and Alcohol Dependence 125 2012 173 177
70. R.A. Fuchs, L.T. Tran-Nguyen, S.E. Specio, R.S. Groff, and J.L. Neisewander Predictive validity of the extinction/reinstatement model of drug craving Psychopharmacology (Berl) 135 1998 151 160 (Pubitemid 28055498)
71. R.A. Fuchs, L.T. Tran-Nguyen, S.M. Weber, T.V. Khroyan, and J.L. Neisewander Effects of 7-OH-DPAT on cocaine-seeking behavior and on re-establishment of cocaine self-administration Pharmacol. Biochem. Behav. 72 2002 623 632 (Pubitemid 34450862)
72. K. Fuxe, D. Marcellino, D.O. Borroto-Escuela, M. Guescini, V. Fernandez-Duenas, S. Tanganelli, A. Rivera, F. Ciruela, and L.F. Agnati Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders Cns Neurosci. Ther. 16 2010 e18 e42
73. K. Gál, and I. Gyertyán Dopamine D3 as well as D2 receptor ligands attenuate the cue-induced cocaine-seeking in a relapse model in rats Drug Alcohol Depend. 81 2006 63 70 (Pubitemid 41682480)
74. 3 receptor cannot influence continuous reinforcement cocaine self-administration in rats Brain Res. Bull. 61 2003 595 601 (Pubitemid 37163541)
75. F.H. Gawin, and H.D. Kleber Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations Arch. Gen. Psychiatry 43 1986 107 113 (Pubitemid 16163529)
76. A. Ghavami, K.L. Stark, M. Jareb, S. Ramboz, L. Segu, and R. Hen Differential addressing of 5-HT1A and 5-HT1B receptors in epithelial cells and neurons J. Cell Sci. 112 Pt 6 1999 967 976 (Pubitemid 29179329)
77. J.G. Gilbert, A.H. Newman, E.L. Gardner, C.R. Ashby Jr., C.A. Heidbreder, A.C. Pak, X.Q. Peng, and Z.X. Xi Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors Synapse 57 2005 17 28 (Pubitemid 40756331)
78. P.K. Gillman Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review Headache 50 2010 264 272
79. G.M. Goodwin, and A.R. Green A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors Br. J. Pharmacol. 84 1985 743 753 (Pubitemid 15029918)
80. 1 receptor agonist in rodents and the effect on the behaviour of treatment with antidepressants Neuropharmacology 23 1984 655 661 (Pubitemid 14107457)
81. J.W. Grimm, B.T. Hope, R.A. Wise, and Y. Shaham Neuroadaptation - incubation of cocaine craving after withdrawal Nature 412 2001 141 142 (Pubitemid 32674700)
82. P. Grundt, K.M. Prevatt, J.J. Cao, M. Taylor, C.Z. Floresca, J.K. Choi, B.G. Jenkins, R.R. Luedtke, and A.H. Newman Heterocyclic analogues of N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents J. Med. Chem. 50 2007 4135 4146 (Pubitemid 47301745)
83. I. Gyertyán, B. Kiss, K. Gál, I. Laszlovszky, A. Horváth, L.I. Gémesi, K. Sághy, G. Pásztor, M. Zájer, M. Kapás, E.A. Csongor, G. Domány, K. Tihanyi, and Z. Szombathelyi Effects of RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin- 1-yl]-butyl}-4-bromo-benzami de], an orally active, selective dopamine D-3 receptor partial agonist in animal models of cocaine abuse J. Pharmacol. Exp. Ther. 320 2007 1268 1278
84. I. Gyertyán, and K. Sághy The selective dopamine D3 receptor antagonists, SB 277011-A and S 33084 block haloperidol-induced catalepsy in rats Eur. J. Pharmacol. 572 2007 171 174 (Pubitemid 47429649)
85. J.C. Halford, and J.E. Blundell The 5-HT1B receptor agonist CP-94,253 reduces food intake and preserves the behavioural satiety sequence Physiol. Behav. 60 1996 933 939 (Pubitemid 26284299)
86. M. Haney, E. Rubin, and R.W. Foltin Aripiprazole maintenance increases smoked cocaine self-administration in humans Psychopharmacology 216 2011 379 387
87. Y. Hasegawa, S. Higuchi, S. Matsushita, and H. Miyaoka Association of a polymorphism of the serotonin 1B receptor gene and alcohol dependence with inactive aldehyde dehydrogenase-2 J. Neural. Transm. 109 2002 513 521. (Pubitemid 34280409)
88. C.A. Heidbreder, E.L. Gardner, Z.X. Xi, P.K. Thanos, M. Mugnaini, J.J. Hagan, and C.R. Ashby The role of central dopamine D-3 receptors in drug addiction: a review of pharmacological evidence Brain Res. Rev. 49 2005 77 105 (Pubitemid 40800164)
89. A.E. Higley, S.W. Kiefer, X. Li, J. Gaal, Z.X. Xi, and E.L. Gardner Dopamine D3 receptor antagonist SB-277011A inhibits methamphetamine self-administration and methamphetamine-induced reinstatement of drug-seeking in rats Eur. J. Pharmacol. 659 2011 187 192
90. A.E. Higley, K. Spiller, P. Grundt, A.H. Newman, S.W. Kiefer, Z.X. Xi, and E.L. Gardner PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats J. Psychopharmacol. 25 2011 263 273
91. M.E. Hoefer, S.J. Voskanian, G.F. Koob, and L. Pulvirenti Effects of terguride, ropinirole, and acetyl-L-carnitine on methamphetamine withdrawal in the rat Pharmacol. Biochem. Behav. 83 2006 403 409
92. B.J. Hoplight, E.S. Vincow, and J.F. Neumaier Cocaine increases 5-HT1B mRNA in rat nucleus accumbens shell neurons Neuropharmacology 52 2007 444 449 (Pubitemid 46123360)
93. J. Hu, S. Henry, J.D. Gallezot, J. Ropchan, J.F. Neumaier, M.N. Potenza, R. Sinha, J.H. Krystal, Y. Huang, Y.S. Ding, R.E. Carson, and A. Neumeister Serotonin 1B receptor imaging in alcohol dependence Biol. Psychiatry 67 2010 800 803
94. Y.Y. Huang, M.A. Oquendo, J.M. Friedman, L.L. Greenhill, B. Brodsky, K.M. Malone, V. Khait, and J.J. Mann Substance abuse disorder and major depression are associated with the human 5-HT1B receptor gene (HTR1B) G861C polymorphism Neuropsychopharmacology 28 2003 163 169
95. E. Izzo, C. Orsini, G.F. Koob, and L. Pulvirenti A dopamine partial agonist and antagonist block amphetamine self-administration in a progressive ratio schedule Pharmacol. Biochem. Behav. 68 2001 701 708 (Pubitemid 32411607)
96. J.H. Jaffe, N.G. Cascella, K.M. Kumor, and M.A. Sherer Cocaine-induced cocaine craving Psychopharmacology (Berl) 97 1989 59 64 (Pubitemid 19020384)
97. J.N. Joyce, and M.J. Millan Dopamine D3 receptor antagonists as therapeutic agents Drug Discov. Today 10 2005 917 925 (Pubitemid 40922790)
98. P.W. Kalivas The glutamate homeostasis hypothesis of addiction Nat. Rev. Neurosci. 10 2009 561 572
99. P.W. Kalivas, and N.D. Volkow The neural basis of addiction: a pathology of motivation and choice Am. J. Psychiatry 162 2005 1403 1413 (Pubitemid 41105554)
100. H.O. Kalkman Ru-24969-induced locomotion in rats is mediated by 5ht(1a) receptors Naunyn-Schmiedebergs Arch. Pharmacol. 352 1995 583 584
101. T.V. Khroyan, D.A. Baker, and J.L. Neisewander Dose-dependent effects of the D-3-preferring agonist 7-OH-DPAT on motor behaviors and place conditioning Psychopharmacology 122 1995 351 357 (Pubitemid 26011416)
102. T.V. Khroyan, R.L. Barrett-Larimore, J.K. Rowlett, and R.D. Spealman Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists J Pharmacol. Exp. Ther. 294 2000 680 687 (Pubitemid 30490845)
103. B.J. Kinon, and J.A. Lieberman Mechanisms of action of atypical antipsychotic drugs: a critical analysis Psychopharmacology 124 1996 2 34 (Pubitemid 26111436)
104. E.A. Kiyatkin, and E.A. Stein Biphasic changes in mesolimbic dopamine signal during cocaine self-administration Neuroreport 5 1994 1005 1008 (Pubitemid 24138120)
105. B.K. Koe, J.A. Nielsen, J.E. Macor, and J. Heym Biochemical and behavioral-studies of the 5-Ht(1b) receptor agonist, Cp-94,253 Drug Dev. Res. 26 1992 241 250
106. M.N. Koffarnus, G.T. Collins, K.C. Rice, J.Y. Chen, J.H. Woods, and G. Winger Self-administration of agonists selective for dopamine D-2, D-3, and D-4 receptors by rhesus monkeys Behav. Pharmacol. 23 2012 331 338
107. H. Kong, W. Kuang, S. Li, and M. Xu Activation of dopamine D3 receptors inhibits reward-related learning induced by cocaine Neuroscience 176 2011 152 161
108. G.F. Koob, S.H. Ahmed, B. Boutrel, S.A. Chen, P.J. Kenny, A. Markou, L.E. O'Dell, L.H. Parsons, and P.P. Sanna Neurobiological mechanisms in the transition from drug use to drug dependence Neurosci. Biobehav. Rev. 27 2004 739 749 (Pubitemid 38199606)
109. G.F. Koob, S.B. Caine, L. Parsons, A. Markou, and F. Weiss Opponent process model and psychostimulant addiction Pharmacol. Biochem. Behav. 57 1997 513 521 (Pubitemid 27296763)
110. L.M. Koran, S. Pallanti, and L. Quercioli Sumatriptan, 5-HT(1D) receptors and obsessive-compulsive disorder Eur. Neuropsychopharmacol. 11 2001 169 172 (Pubitemid 32335559)
111. N.S. Kula, R.J. Baldessarini, J.W. Kebabian, and J.L. Neumeyer S-(+)-aporphines are not selective for human D 3 dopamine receptors Cell. Mol. Neurobiol. 14 1994 185 191 (Pubitemid 24313468)
112. R. Kumar, L.R. Riddle, S.A. Griffin, W.H. Chu, S. Vangveravong, J. Neisewander, R.H. Mach, and R.R. Luedtke Evaluation of D2 and D3 dopamine receptor selective compounds on L-dopa-dependent abnormal involuntary movements in rats Neuropharmacology 56 2009 956 969
113. B. Le Foll, H. Frances, J. Diaz, J.C. Schwartz, and P. Sokoloff Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice Eur. J. Neurosci. 15 2002 2016 2026 (Pubitemid 35471890)
114. M.D. Lee, G.A. Kennett, C.T. Dourish, and P.G. Clifton 5-HT1B receptors modulate components of satiety in the rat: behavioural and pharmacological analyses of the selective serotonin1B agonist CP-94,253 Psychopharmacology (Berl) 164 2002 49 60 (Pubitemid 35203842)
115. M.D. Lee, and K.J. Simansky CP-94,253: a selective serotonin(1B) (5-HT1B) agonist that promotes satiety Psychopharmacology 131 1997 264 270 (Pubitemid 27283588)
116. S.Y. Lee, W.W. Lin, S.Y. Huang, P.H. Kuo, C.L. Wang, P.L. Wu, S.L. Chen, J.Y. Wu, H.C. Ko, and R.B. Lu The relationship between serotonin receptor 1B polymorphisms A-161T and alcohol dependence Alcohol Clin. Exp. Res. 33 2009 1589 1595
117. F. Leri, J. Bruneau, and J. Stewart Understanding polydrug use: review of heroin and cocaine co-use Addiction 98 2003 7 22 (Pubitemid 36044332)
118. S.M. Li, G.T. Collins, N.M. Paul, P. Grundt, A.H. Newman, M. Xu, D.K. Grandy, J.H. Woods, and J.L. Katz Yawning and locomotor behavior induced by dopamine receptor agonists in mice and rats Behav. Pharmacol. 21 2010 171 181
119. J.A. Lile, W.W. Stoops, L.R. Hays, and C.R. Rush The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance II: increased aripiprazole dose and maintenance period Am. J. Drug Alcohol Abuse 34 2008 721 729
120. D. Lin, and L.H. Parsons Anxiogenic-like effect of serotonin(1B) receptor stimulation in the rat elevated plus-maze Pharmacol. Biochem. Behav. 71 2002 581 587 (Pubitemid 34219208)
121. R.R. Luedtke, Y. Mishra, Q. Wang, S.A. Griffin, C. Bell-Horner, M. Taylor, S. Vangveravong, G.H. Dillon, R.Q. Huang, D.E. Reichert, and R.H. Mach Comparison of the binding and functional properties of two structurally different D2 dopamine receptor subtype selective compounds Acs Chem. Neurosci. 3 2012 1050 1062
122. R.H. Mach, Z.D. Tu, J.B. Xu, S.H. Li, L.A. Jones, M. Taylor, R.R. Luedtke, C.P. Derdeyn, J.S. Perlmutter, and M.A. Mintun Endogenous dopamine (DA) competes with the binding of a radiolabeled D-3 receptor partial agonist in vivo: a positron emission tomography study Synapse 65 2011 724 732
123. R.G. Mackenzie, D. Vanleeuwen, T.A. Pugsley, Y.H. Shih, S. Demattos, L. Tang, R.D. Todd, and K.L. Omalley Characterization of the human dopamine D3 receptor expressed in transfected cell lines Eur. J. Pharmacol. Mol. Pharmacol. Sect. 266 1994 79 85
124. J.E. Macor, C.A. Burkhart, J.H. Heym, J.L. Ives, L.A. Lebel, M.E. Newman, J.A. Nielsen, K. Ryan, D.W. Schulz, L.K. Torgersen, and B.K. Koe 3-(1,2,5,6-Tetrahydropyrid-4-Yl)pyrrolo[3,2-B]pyrid-5-one - a potent and selective serotonin (5-Ht1b) agonist and rotationally restricted phenolic analog of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-Yl)indole J. Med. Chem. 33 1990 2087 2093 (Pubitemid 20236649)
125. R.B. Mailman GPCR functional selectivity has therapeutic impact Trends Pharmacol. Sci. 28 2007 390 396 (Pubitemid 47087963)
126. D. Marcellino, D.C.S. Roberts, G. Navarro, M. Filip, L. Agnati, C. Lluis, R. Franco, and K. Fuxe Increase in A(2A) receptors in the nucleus accumbens after extended cocaine self-administration and its disappearance after cocaine withdrawal Brain Re. 1143 2007 208 220 (Pubitemid 46440826)
127. M. Marinelli, D.C. Cooper, L.K. Baker, and F.J. White Impulse activity of midbrain dopamine neurons modulates drug-seeking behavior Psychopharmacology 168 2003 84 98 (Pubitemid 36851166)
128. A. Markou, F. Weiss, L.H. Gold, S.B. Caine, G. Schulteis, and G.F. Koob Animal models of drug craving Psychopharmacology (Berl) 112 1993 163 182 (Pubitemid 23278275)
129. J.L. Martelle, R. Claytor, J.T. Ross, B.A. Reboussin, A.H. Newman, and M.A. Nader Effects of two novel D-3-selective compounds, NGB 2904 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide] and CJB 090 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl) benzamide], on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys J. Pharmacol. Exp. Ther. 321 2007 573 582 (Pubitemid 46624484)
130. R.B. McCall, K.J. Lookingland, P.J. Bedard, and R.M. Huff Sumanirole, a highly dopamine D2-selective receptor agonist: in vitro and in vivo pharmacological characterization and efficacy in animal models of Parkinson's disease J. Pharmacol. Exp. Ther. 314 2005 1248 1256 (Pubitemid 41205991)
131. R.A. McDevitt, R. Hiroi, S.M. Mackenzie, N.C. Robin, A. Cohn, J.J. Kim, and J.F. Neumaier Serotonin 1B autoreceptors originating in the caudal dorsal raphe nucleus reduce expression of fear and depression-like behavior Biol. Psychiatry 69 2011 780 787
132. B.S. McEwen Allostasis and allostatic load: implications for neuropsychopharmacology Neuropsychopharmacology 22 2000 108 124
133. M. Meini, M. Moncini, D. Cecconi, V. Cellesi, L. Biasci, G. Simoni, M. Ameglio, M. Pellegrini, R.N. Forgione, and P. Rucci Safety, tolerability, and self-rated effects of aripiprazole and ropinirole treatment for cocaine dependence: a pilot study Am. J. Addict. 20 2011 179 180
134. N.K. Mello, and S.S. Negus Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures Neuropsychopharmacology 14 1996 375 424 (Pubitemid 26271172)
135. M.J. Millan, L. Maiofiss, D. Cussac, V. Audinot, J.A. Boutin, and A. Newman-Tancredi Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes J. Pharmacol. Exp. Ther. 303 2002 791 804 (Pubitemid 35231256)
136. M.J. Millan, C. Mannoury la Cour, F. Novi, R. Maggio, V. Audinot, A. Newman-Tancredi, D. Cussac, V. Pasteau, J.A. Boutin, T. Dubuffet, and G. Lavielle S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]- benzopyrano[3,4-c]pyrr ol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I.
137. M.J. Millan, J.L. Peglion, J. Vian, J.M. Rivet, M. Brocco, A. Gobert, A. Newmantancredi, C. Dacquet, K. Bervoets, S. Girardon, V. Jacques, C. Chaput, and V. Audinot Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy J. Pharmacol. Exp. Ther. 275 1995 885 898 (Pubitemid 26027050)
138. M.J. Millan, L. Seguin, A. Gobert, D. Cussac, and M. Brocco The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats Psychopharmacology 174 2004 341 357 (Pubitemid 39044292)
139. D.D. Miller, J.M. Eudicone, A. Pikalov, and E. Kim Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis J. Clin. Psychiatry 68 2007 1901 1906
140. N.S. Miller, G.L. Summers, and M.S. Gold Cocaine dependence: alcohol and other drug dependence and withdrawal characteristics J. Addict. Dis. 12 1993 25 35 (Pubitemid 23056809)
141. J. Miszkiel, P. Adamczyk, M. Filip, and E. Przegalinski The effect of serotonin 5HT(1B) receptor ligands on amphetamine self-administration in rats Eur. J. Pharmacol. 677 2012 111 115
142. D. Morgan, K. Brebner, W.J. Lynch, and D.C.S. Roberts Increases in the reinforcing efficacy of cocaine after particular histories of reinforcement Behav. Pharmacol. 13 2002 389 396 (Pubitemid 35178836)
143. D. Morgan, K.A. Grant, H.D. Gage, R.H. Mach, J.R. Kaplan, O. Prioleau, S.H. Nader, N. Buchheimer, R.L. Ehrenkaufer, and M.A. Nader Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration Nat. Neurosci. 5 2002 169 174 (Pubitemid 34121585)
144. M.A. Nader, K.L. Green, R.R. Luedtke, and R.H. Mach The effects of benzamide analogues on cocaine self-administration in rhesus monkeys Psychopharmacology 147 1999 143 152 (Pubitemid 30010561)
145. M.A. Nader, S.H. Nader, P.W. Czoty, N.V. Riddick, H.D. Gage, R.W. Gould, B.L. Blaylock, J.R. Kaplan, P.K. Garg, H.M. Davies, D. Morton, S. Garg, and B.A. Reboussin Social dominance in female monkeys: dopamine receptor function and cocaine reinforcement Biol. Psychiatry 72 2012 414 421
146. S.S. Negus Rapid assessment of choice between cocaine and food in rhesus monkeys: effects of environmental manipulations and treatment with d-amphetamine and flupenthixol Neuropsychopharmacology 28 2003 919 931
147. J.L. Neisewander, D.A. Baker, R.A. Fuchs, L.T.L. Tran-Nguyen, A. Palmer, and J.F. Marshall Fos protein expression and cocaine-seeking behavior in rats after exposure to a cocaine self-administration environment J. Neurosci. 20 2000 798 805 (Pubitemid 30225582)
148. J.L. Neisewander, R.A. Fuchs, L.T. Tran-Nguyen, S.M. Weber, G.P. Coffey, and J.N. Joyce Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: implications for cocaine-seeking behavior Neuropsychopharmacology 29 2004 1479 1487 (Pubitemid 38982240)
149. J.L. Neisewander, N.A. Peartree, and N.S. Pentkowski Emotional valence and context of social influences on drug abuse-related behavior in animal models of social stress and prosocial interaction Psychopharmacology 224 2012 33 56
150. J.F. Neumaier, R.A. McDevitt, I.Y. Polis, and L.H. Parsons Acquisition of and withdrawal from cocaine self-administration regulates 5-HT mRNA expression in rat striatum J. Neurochem. 111 2009 217 227
151. J.F. Neumaier, E.S. Vincow, A. Arvanitogiannis, R.A. Wise, and W.A. Carlezon Jr. Elevated expression of 5-HT1B receptors in nucleus accumbens efferents sensitizes animals to cocaine J. Neurosci. 22 2002 10856 10863 (Pubitemid 36005160)
152. A.H. Newman, B.L. Blaylock, M.A. Nader, J. Bergman, D.R. Sibley, and P. Skolnick Medication discovery for addiction: translating the dopamine D3 receptor hypothesis Biochem. Pharmacol. 84 2012 882 890
153. A.H. Newman, P. Grundt, and M.A. Nader Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents J. Med. Chem. 48 2005 3663 3679 (Pubitemid 40776839)
154. K. Nonogaki, K. Nozue, Y. Takahashi, N. Yamashita, S. Hiraoka, H. Kumano, T. Kuboki, and Y. Oka Fluvoxamine, a selective serotonin reuptake inhibitor, and 5-HT2C receptor inactivation induce appetite-suppressing effects in mice via 5-HT1B receptors Int. J. Neuropsychopharmacol. 10 2007 675 681 (Pubitemid 47517517)
155. L.E. O'Dell, A.M. Manzardo, I. Polis, D.G. Stouffer, and L.H. Parsons Biphasic alterations in serotonin-1B (5-HT1B) receptor function during abstinence from extended cocaine self-administration J. Neurochem. 99 2006 1363 1376 (Pubitemid 44730091)
156. L.E. O'Dell, and L.H. Parsons Serotonin1B receptors in the ventral tegmental area modulate cocaine-induced increases in nucleus accumbens dopamine levels J. Pharmacol. Exp. Ther. 311 2004 711 719 (Pubitemid 39391559)
157. M.F. O'Neill, and T. Parameswaran RU24969-induced behavioural syndrome requires activation of both 5HT1A and 5HT1B receptors Psychopharmacology (Berl) 132 1997 255 260 (Pubitemid 27351426)
158. 1 agonist RU 24969 and effects on dopaminergic behaviour Eur. J. Pharmacol. 139 1987 205 214 (Pubitemid 17101123)
159. L. Orio, S. Wee, A.H. Newman, L. Pulvirenti, and G.F. Koob The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access Addict. Biol. 15 2010 312 323
160. C. Orsini, G.F. Koob, and L. Pulvirenti Dopamine partial agonist reverses amphetamine withdrawal in rats Neuropsychopharmacology 25 2001 789 792 (Pubitemid 32995961)
161. K. Ossowska Neuronal basis of neuroleptic-induced extrapyramidal side effects Pol. J. Pharmacol. 54 2002 299 312
162. L.H. Parsons, G.F. Koob, and F. Weiss Serotonin dysfunction in the nucleus-accumbens of rats during withdrawal after unlimited access to intravenous cocaine J. Pharmacol. Exp. Ther. 274 1995 1182 1191
163. L.H. Parsons, F. Weiss, and G.F. Koob Serotonin1b receptor stimulation enhances dopamine-mediated reinforcement Psychopharmacology (Berl) 128 1996 150 160 (Pubitemid 26383302)
164. L.H. Parsons, F. Weiss, and G.F. Koob Serotonin1B receptor stimulation enhances cocaine reinforcement J. Neurosci. 18 1998 10078 10089 (Pubitemid 28543782)
165. M.S. Peña, T.C. Yaltho, and J. Jankovic Tardive dyskinesia and other movement disorders secondary to aripiprazole Mov. Disord. 26 2010 147 152
166. X.Q. Peng, C.R. Ashby, K. Spiller, X. Li, J. Li, N. Thomasson, M.J. Millan, E. Mocaer, C. Munoz, E.L. Gardner, and Z.X. Xi The preferential dopamine D3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in rats Neuropharmacology 56 2009 752 760
167. N.S. Pentkowski, J.I. Acosta, J.R. Browning, E.C. Hamilton, and J.L. Neisewander Stimulation of 5-HT(1B) receptors enhances cocaine reinforcement yet reduces cocaine-seeking behavior Addict. Biol. 14 2009 419 430
168. N.S. Pentkowski, T.H. Cheung, W.A. Toy, M.D. Adams, J.F. Neumaier, and J.L. Neisewander Protracted withdrawal from cocaine self-administration flips the switch on 5-HT(1B) receptor modulation of cocaine abuse-related behaviors Biol. Psychiatry 72 5 2012 396 404
169. N.S. Pentkowski, B. Harder, S. Brunwasser, K. Yanamandra, R.M. Bastle, T. Der-Ghazarian, M.D. Adams, J. Alba, and J.L. Neisewander The effects of 5-HT1B receptors on motivation for cocaine vary depending on the length of abstinence Soc. Neurosci. 2012 Poster # 779.20/JJ10
170. K.L. Pian, H.G. Westenberg, H.J. van Megen, and J.A. den Boer Sumatriptan (5-HT1D receptor agonist) does not exacerbate symptoms in obsessive compulsive disorder Psychopharmacology (Berl) 140 1998 365 370 (Pubitemid 28562456)
171. M. Pilla, S. Perachon, F. Sautel, F. Garrido, A. Mann, C.G. Wermuth, J.C. Schwartz, B.J. Everitt, and P. Sokoloff Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist Nature 400 1999 371 375 (Pubitemid 29344203)
172. D.M. Platt, J.S. Rodefer, J.K. Rowlett, and R.D. Spealman Suppression of cocaine- and food-maintained behavior by the D2-like receptor partial agonist terguride in squirrel monkeys Psychopharmacology 166 2003 298 305 (Pubitemid 36384778)
173. L.J. Porrino, H.R. Smith, M.A. Nader, and T.J.R. Beveridge The effects of cocaine: a shifting target over the course of addiction Prog. Neuro-Psychopharmacol. Biol. Psychiatry 31 2007 1593 1600 (Pubitemid 47625705)
174. A. Preti New developments in the pharmacotherapy of cocaine abuse Addict. Biol. 12 2007 133 151 (Pubitemid 46753646)
175. M. Prinzleve, C. Haasen, H. Zurhold, J.L. Matali, E. Bruguera, J. Gerevich, E. Bacskai, N. Ryder, S. Butler, V. Manning, M. Gossop, A.M. Pezous, A. Verster, A. Camposeragna, P. Andersson, B. Olsson, A. Primorac, G. Fischer, F. Guttinger, J. Rehm, and M. Krausz Cocaine use in Europe - a multi-centre study: patterns of use in different groups Eur. Addict. Res. 10 2004 147 155 (Pubitemid 40069605)
176. D. Proudnikov, K.S. LaForge, H. Hofflich, M. Levenstien, D. Gordon, S. Barral, J. Ott, and M.J. Kreek Association analysis of polymorphisms in serotonin 1B receptor (HTR1B) gene with heroin addiction: a comparison of molecular and statistically estimated haplotypes Pharmacogenet. Genomics 16 2006 25 36 (Pubitemid 41803874)
177. E. Przegalinski, K. Czepiel, E. Nowak, D. Dlaboga, and M. Filip Withdrawal from chronic cocaine up-regulates 5-HT1B receptors in the rat brain Neurosci. Lett. 351 2003 169 172 (Pubitemid 37410331)
178. E. Przegalinski, A. Golda, and M. Filip Effects of serotonin (5-HT) (1B) receptor ligands on cocaine-seeking behavior in rats Pharmacol. Rep. 60 2008 798 810
179. E. Przegalinski, A. Golda, M. Frankowska, M. Zaniewska, and M. Filip Effects of serotonin 5-HT1B receptor ligands on the cocaine- and food-maintained self-administration in rats Eur. J. Pharmacol. 559 2007 165 172
180. L. Pulvirenti, C. Balducci, M. Piercy, and G.F. Koob Characterization of the effects of the partial dopamine agonist terguride on cocaine self-administration in the rat J. Pharmacol. Exp. Ther. 286 1998 1231 1238 (Pubitemid 29135534)
181. L. Pulvirenti, and G.F. Koob Being partial to psychostimulant addiction therapy Trends Pharmacol. Sci. 23 2002 151 153 (Pubitemid 34270586)
182. C. Reavill, S.G. Taylor, M.D. Wood, T. Ashmeade, N.E. Austin, K.Y. Avenell, I. Boyfield, C.L. Branch, J. Cilia, M.C. Coldwell, M.S. Hadley, A.J. Hunter, P. Jeffrey, F. Jewitt, C.N. Johnson, D.N.C. Jones, A.D. Medhurst, D.N. Middlemiss, D.J. Nash, G.J. Riley, C. Routledge, G. Stemp, K.M. Thewlis, B. Trail, A.K.K. Vong, and J.J. Hagan Pharmacological actions of a novel, high-affinity, and selective human dopamine D-3 receptor antagonist, SB-277011-A J. Pharmacol. Exp. Ther. 294 2000 1154 1165 (Pubitemid 30666872)
183. M.E. Reith, M.Y. Li, and Q.S. Yan Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers Psychopharmacology (Berl) 134 1997 309 317 (Pubitemid 27520985)
184. M. Riad, S. Garcia, K.C. Watkins, N. Jodoin, E. Doucet, X. Langlois, S. el Mestikawy, M. Hamon, and L. Descarries Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain J. Comp. Neurol. 417 2000 181 194 (Pubitemid 30038263)
185. S. Ridray, N. Griffon, V. Mignon, E. Souil, S. Carboni, J. Diaz, J.C. Schwartz, and P. Sokoloff Coexpression of dopamine D-1 and D-3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions Eur. J. Neurosci. 10 1998 1676 1686 (Pubitemid 28327315)
186. T.E. Robinson, and K.C. Berridge The psychology and neurobiology of addiction: an incentive-sensitization view Addiction 95 Suppl. 2 2000 S91 S117
187. P.E. Rolan Drug interactions with triptans: which are clinically significant? CNS Drugs 26 2012 949 957
188. G.A. Rowan-Szal, L.R. Chatham, and D.D. Simpson Importance of identifying cocaine and alcohol dependent methadone clients Am. J. Addict. 9 2000 38 50 (Pubitemid 30155032)
189. J.D. Salamone, and M. Correa Dopamine/adenosine interactions involved in effort-related aspects of food motivation Appetite 53 2009 422 425
190. J.D. Salamone, and M. Correa The mysterious motivational functions of mesolimbic dopamine Neuron 76 2012 470 485
191. J.D. Salamone, M. Correa, A.M. Farrar, E.J. Nunes, and M. Pardo Dopamine, behavioral economics, and effort Front. Behav. Neurosci. 3 2009 12
192. Y. Sari, K. Lefevre, M. Bancila, M. Quignon, M.C. Miquel, X. Langlois, M. Hamon, and D. Verge Light and electron microscopic immunocytochemical visualization of 5-HT1B receptors in the rat brain Brain Res. 760 1997 281 286 (Pubitemid 27304166)
193. Y. Sari, M.C. Miquel, M.J. Brisorgueil, G. Ruiz, E. Doucet, M. Hamon, and D. Verge Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies Neuroscience 88 1999 899 915 (Pubitemid 28518266)
194. Y. Sari Role of 5-hydroxytryptamine 1B (5-HT1B) receptors in the regulation of ethanol intake in rodents J. Psychopharmacol. 27 1 2013 3 12
195. F. Sautel, N. Griffon, D. Levesque, C. Pilon, J.C. Schwartz, and P. Sokoloff A functional test identifies dopamine agonists selective for D3 versus D2 receptors Neuroreport 6 1995 329 332
196. H.D. Schmidt, and R.C. Pierce Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat Neuroscience 142 2006 451 461 (Pubitemid 44430040)
197. W. Schultz, P. Dayan, and P.R. Montague A neural substrate of prediction and reward Science 275 1997 1593 1599 (Pubitemid 27120526)
198. K. Schwabe, and M. Koch Effects of aripiprazole on operant responding for a natural reward after psychostimulant withdrawal in rats Psychopharmacology 191 2007 759 765 (Pubitemid 46355881)
199. D.A. Sclar, L.M. Robison, L.V. Castillo, J.M. Schmidt, K.A. Bowen, A.M. Oganov, T.L. Skaer, and S.J. Kogut Concomitant use of triptan, and SSRI or SNRI after the US Food and Drug Administration alert on serotonin syndrome Headache 52 2012 198 203
200. 3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities Mol. Brain Res. 45 1997 335 339 (Pubitemid 27170712)
201. D.W. Self, W.J. Barnhart, D.A. Lehman, and E.J. Nestler Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists Science 271 1996 1586 1589 (Pubitemid 26097217)
202. Y. Shaham, U. Shalev, L. Lu, H. De Wit, and J. Stewart The reinstatement model of drug relapse: history, methodology and major findings Psychopharmacology (Berl) 168 2003 3 20 (Pubitemid 36851158)
203. D.A. Shapiro, S. Renock, E. Arrington, L.A. Chiodo, L.X. Liu, D.R. Sibley, B.L. Roth, and R. Mailman Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology Neuropsychopharmacology 28 2003 1400 1411 (Pubitemid 41070874)
204. R. Sinha, D. Catapano, and S. O'Malley Stress-induced craving and stress response in cocaine dependent individuals Psychopharmacology 142 1999 343 351 (Pubitemid 29187622)
205. P. Sokoloff, J. Diaz, B. Le Foll, O. Guillin, L. Leriche, E. Bezard, and C. Gross The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders CNS Neurol. Disord.-Drug Targets 5 2006 25 43 (Pubitemid 43796626)
206. R. Song, R.F. Yang, N. Wu, R.B. Su, J. Li, X.Q. Peng, X. Li, J. Gaal, Z.X. Xi, and E.L. Gardner YQA14: a novel dopamine D-3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D-3 receptor-knockout mice Addict. Biol. 17 2012 259 273
207. R. Song, H.Y. Zhang, X. Li, G.H. Bi, E.L. Gardner, and Z.X. Xi Increased vulnerability to cocaine in mice lacking dopamine D-3 receptors Proc. Nat. Acad. Sci. U. S. A. 109 2012 17675 17680
208. G. Sørensen, T.N. Sager, J.H. Petersen, L.T. Brennum, P. Thøgersen, C.H. Bengtsen, M. Thomsen, G. Wörtwein, A. Fink-Jensen, and D.P.D. Woldbye Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice Psychopharmacology 199 2008 37 46
209. 3 dopamine receptors in the brain reward circuits of human cocaine fatalities J. Neurosci. 16 1996 6100 6106 (Pubitemid 26313985)
210. L. Stern, J. Zohar, R. Cohen, and Y. Sasson Treatment of severe, drug resistant obsessive compulsive disorder with the 5HT1D agonist sumatriptan Eur. Neuropsychopharmacol. 8 1998 325 328 (Pubitemid 28557029)
211. J. Stewart Conditioned and unconditioned drug effects in relapse to opiate and stimulant drug self-administration Prog. Neuropsychopharmacol. Biol. Psychiatry 7 1983 591 597 (Pubitemid 14214984)
212. W.W. Stoops, J.A. Lile, M.R. Lofwall, and C.R. Rush The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance Am. J. Drug Alcohol Abuse 33 2007 769 776 (Pubitemid 350125771)
213. H.F. Sun, Y.T. Chang, C.S. Fann, C.J. Chang, Y.H. Chen, Y.P. Hsu, W.Y. Yu, and A.T. Cheng Association study of novel human serotonin 5-HT(1B) polymorphisms with alcohol dependence in Taiwanese Han Biol. Psychiatry 51 2002 896 901 (Pubitemid 34521938)
214. Y. Tadori, R.A. Forbes, R.D. McQuade, and T. Kikuchi Characterization of aripiprazole partial agonist activity at human dopamine D-3 receptors Eur. J. Pharmacol. 597 2008 27 33
215. E. Tatarczynska, A. Klodzinska, K. Stachowicz, and E. Chojnacka-Wojcik Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxiety and depression Behav. Pharmacol. 15 2004 523 534 (Pubitemid 40075900)
216. D. Taylor, A.J. Lincoln, and S.L. Foster Impaired behavior regulation under conditions of concurrent variable schedules of reinforcement in children with ADHD J. Atten. Disord. 13 2010 358 368
217. P.K. Thanos, M. Michaelides, C.W. Ho, G.J. Wang, A.H. Newman, C.A. Heidbreder, C.R. Ashby Jr., E.L. Gardner, and N.D. Volkow The effects of two highly selective dopamine D3 receptor antagonists (SB-277011A and NGB-2904) on food self-administration in a rodent model of obesity Pharmacol. Biochem. Behav. 89 2008 499 507
218. K.J. Thiel, J.M. Wenzel, N.S. Pentkowski, R.J. Hobbs, A.T. Alleweireldt, and J.L. Neisewander Stimulation of dopamine D2/D3 but not D1 receptors in the central amygdala decreases cocaine-seeking behavior Behav. Brain Res. 214 2010 386 394
219. M. Thomsen, A. Fink-Jensen, D.P.D. Woldbye, G. Wortwein, T.N. Sager, R. Holm, L.M. Pepe, and S.B. Caine Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in rats Psychopharmacology 201 2008 43 53
220. S.T. Tiffany, and B.L. Carter Is craving the source of compulsive drug use? J. Psychopharmacol. 12 1998 23 30 (Pubitemid 28142996)
221. J. Tiihonen, K. Kuoppasalmi, J. Fohr, P. Tuomola, O. Kuikanmaki, H. Vorma, P. Sokero, J. Haukka, and E. Meririnne A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence Am. J. Psychiatry 164 2007 160 162 (Pubitemid 46154797)
222. D.M. Tomkins, and M.F. O'Neill Effect of 5-HT(1B) receptor ligands on self-administration of ethanol in an operant procedure in rats Pharmacol. Biochem. Behav. 66 2000 129 136 (Pubitemid 30317526)
223. L.T. Tran-Nguyen, R.A. Fuchs, G.P. Coffey, D.A. Baker, L.E. O'Dell, and J.L. Neisewander Time-dependent changes in cocaine-seeking behavior and extracellular dopamine levels in the amygdala during cocaine withdrawal Neuropsychopharmacology 19 1998 48 59 (Pubitemid 28255213)
224. Z.D. Tu, S.H. Li, J.Q. Cui, J.B. Xu, M. Taylor, D. Ho, R.R. Luedtke, and R.H. Mach Synthesis and pharmacological evaluation of fluorine-containing D-3 dopamine receptor ligands J. Med. Chem. 54 2011 1555 1564
225. J.D. Urban, W.P. Clarke, M. von Zastrow, D.E. Nichols, B. Kobilka, H. Weinstein, J.A. Javitch, B.L. Roth, A. Christopoulos, P.M. Sexton, K.J. Miller, M. Spedding, and R.B. Mailman Functional selectivity and classical concepts of quantitative pharmacology J. Pharmacol. Exp. Ther. 320 2007 1 13 (Pubitemid 46025713)
226. M.M. Voigt, D.J. Laurie, P.H. Seeburg, and A. Bach Molecular cloning and characterization of a rat brain cDNA encoding a 5-hydroxytryptamine1B receptor The EMBO J. 10 1991 4017 4023 (Pubitemid 21905431)
227. N.D. Volkow, G.J. Wang, J.S. Fowler, J. Logan, S.J. Gatley, R. Hitzemann, A.D. Chen, S.L. Dewey, and N. Pappas Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects Nature 386 1997 830 833 (Pubitemid 27181256)
228. N.D. Volkow, G.J. Wang, F. Telang, J.S. Fowler, J. Logan, A.R. Childress, M. Jayne, Y.M. Ma, and C. Wong Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction J. Neurosci. 26 2006 6583 6588 (Pubitemid 44318339)
229. S.R. Vorel, C.R. Asbhy, M. Paul, X.H. Liu, R. Hayes, J.J. Hagan, D.N. Middlemiss, G. Stemp, and E.L. Gardner Dopamine D-3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward J. Neurosci. 22 2002 9595 9603 (Pubitemid 35356201)
230. F. Vorspan, L. Bellais, L. Keijzer, and J.P. Lepine An open-label study of aripiprazole in nonschizophrenic crack-dependent patients J. Clin. Psychopharmacol. 28 2008 570 572
231. M.L.G. Wadenberg, S. Kapur, A. Soliman, C. Jones, and F. Vaccarino Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats Psychopharmacology 150 2000 422 429 (Pubitemid 30470221)
232. Q. Wang, R.H. Mach, R.R. Luedtke, and D.E. Reichert Subtype selectivity of dopamine receptor Ligands: insights from structure and ligand-based methods J. Chem. Inf. Model. 50 2010 1970 1985
233. A.M. Washton Preventing relapse to cocaine J. Clin. Psychiatry 49 Suppl. 1988 34 38 (Pubitemid 18060335)
234. M. Weber, W.L. Chang, J.P. Durbin, P.E. Park, R.R. Luedtke, R.H. Mach, and N.R. Swerdlow Using prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44 Pharmacol. Biochem. Behav. 93 2009 141 147
235. R.D. Weiss, and M.L. Griffin Craving in hospitalized cocaine abusers as a predictor of outcome Am. J. Drug Alcohol Abuse 21 1995 289 301
236. J.B. Willett, and J.D. Singer Investigating onset, cessation, relapse, and recovery: why you should, and how you can, use discrete-time survival analysis to examine event occurrence J. Consult. Clin. Psychol. 61 1993 952 965 (Pubitemid 24006585)
237. A.W. Wilson, B. Costall, and J.C. Neill Manipulation of operant responding for an ethanol-paired conditioned stimulus in the rat by pharmacological alteration of the serotonergic system J. Psychopharmacol. 14 2000 340 346 (Pubitemid 32059777)
238. R.A. Wise Dopamine, learning and motivation Nat. Rev. Neurosci. 5 2004 483 494 (Pubitemid 38715515)
239. R.A. Wise, P. Newton, K. Leeb, B. Burnette, D. Pocock, and J.B. Justice Jr. Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats Psychopharmacology (Berl) 120 1995 10 20
240. Z.X. Xi, J. Gilbert, A.C. Campos, N. Kline, C.R. Ashby, J.J. Hagan, C.A. Heidbreder, and E.L. Gardner Blockade of mesolimbic dopamine D-3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats Psychopharmacology 176 2004 57 65 (Pubitemid 39506367)
241. Z.X. Xi, J.G. Gilbert, A.C. Pak, C.R. Ashby Jr., C.A. Heidbreder, and E.L. Gardner Selective dopamine D-3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost- variable-payoff fixed-ratio cocaine self-administration in rats Eur. J. Neurosci. 21 2005 3427 3438 (Pubitemid 40961437)
242. Z.X. Xi, A.H. Newman, J.G. Gilbert, A.C. Pak, X.Q. Peng, C.R. Ashby Jr., L. Gitajn, and E.L. Gardner The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats Neuropsychopharmacology 31 2006 1393 1405
243. T. Zetterstrom, T. Sharp, C.A. Marsden, and U. Ungerstedt Invivo measurement of dopamine and its metabolites by intracerebral dialysis - changes after d-amphetamine J. Neurochem. 41 1983 1769 1773 (Pubitemid 14204791)